跳至主要内容
临床试验/NL-OMON46930
NL-OMON46930已完成不适用

Effectiveness of scapulothoracic exercise with myofeedback in patients shoulder complaints - ESTEEM study

Vrije Universiteit0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1. Age between 18 and 60 years;
  • 2. Presence of scapular dyskinesis, defined as aymetrically moving scapulae during forward flexion or abduction.
  • 3. Established diagnosis of SPS by physical therapist. diagnostic criteria voor subacromial shoulder pain:
  • i. Presence of pain during active shoulder elevation.
  • ii. Presence of pain during passive external rotation or isometric resistance against external rotation.
  • iii. Presence of at least two positive test, from the following tests: Hawkins-Kennedy test, isometric resistance external rotation, painful arc test.

排除标准

  • 1. Presence of any of the following items:
  • a. Bilateral shoulder complaints.
  • b. Traumatic onset of shoulder complaints.
  • c. Duration of the shoulder complaints of more than nine months.
  • d. History of one or more surgeries on either shoulder.
  • e. Patient is on the waiting list for shoulder surgery.
  • f. Presence of systemic diseases(for example diabetes, rheumatoid arthritis, COPD).
  • g. Presence of neurological diseases (for example multiple slerosis, or other neurological diseases).
  • 2. Presence of any of the following items in the physical examination
  • a. A limitation of the range of motion of the glenohumeral joint compared to the heterolateral glenohumeral joint.
  • b. Shoulder complaints which can be reproduced by cervical spine physical examination.
  • c. Shoulder complaints which can be reproduced by thoracic spine physical examination.
  • d. Positive horizontal adduction test.
  • e. Positive lag test for any of the following muscles; M. Supraspinatus, M. Infraspinatus, M. Subscapularis.
  • f. Positive tests for glenohumeral instability; apprenhension test, relocation test.
  • 3. Inability to come to the physical therapy clinics for the duration of the intervention.
  • 4. The use of paracetamol, or aspirine, or other non-steroidal anti-inflammatory drugs (ibuprofen, diclofenac, naproxen) during the treatment or refusing to discontinue the use of non-steroidal anti-inflammatory drugs during the study period;
  • 5. Visus or cognitive limitations that inhibit the use of the sEMG devices. The potential participant needs to be able to clearly see, and interpret the screen of the sEMG devices/smartphones. For example blind patients will not be eligable for participation.

研究者

相似试验